Back to Search
DAVID HEAL, M.D.
M.D.
General Practice Physician
NPI: 1538124664Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
15876(PR)ACN1013(FL)
Research & Publications (20)
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD.
PMID 18456311·Pharmacol Biochem Behav·2008
6-review
Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
PMID 18068807·Pharmacol Ther·2008
6-review
Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
PMID 17678630·Biochem Pharmacol·2007
4-observational
Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
PMID 16953648·CNS Drugs·2006
6-review
Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats.
PMID 16783408·Br J Pharmacol·2006
7-preclinical
KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders.
PMID 16007235·CNS Drug Rev·2005
6-review
Pharmacological characterisation of the thermogenic effect of bupropion.
PMID 15363998·Eur J Pharmacol·2004
4-observational
5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354.
PMID 14975675·Neuropharmacology·2004
4-observational
Acute cardiovascular effects of sibutramine in conscious rats.
PMID 14634034·J Pharmacol Exp Ther·2004
7-preclinical
Noradrenaline clearance differs in the frontal cortex and hypothalamus: a dual-probe microdialysis study in freely-moving rats.
PMID 14550918·Neurosci Lett·2003
4-observational
Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus.
PMID 12922931·Br J Pharmacol·2003
7-preclinical
Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors.
PMID 12323384·Eur J Pharmacol·2002
4-observational
Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine.
PMID 12187403·Int J Obes Relat Metab Disord·2002
7-preclinical
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
PMID 12065196·Eur J Pharmacol·2002
7-preclinical
Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release.
PMID 11673765·Int J Obes Relat Metab Disord·2001
7-preclinical
Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine.
PMID 11673764·Int J Obes Relat Metab Disord·2001
7-preclinical
BTS 72664-- a novel CNS drug with potential anticonvulsant, neuroprotective, and antimigraine properties.
PMID 11474422·CNS Drug Rev·2001
6-review
Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y.
PMID 11309262·Br J Pharmacol·2001
7-preclinical
Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats.
PMID 11018791·Synapse·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 CALLE BALDORIOTY
MOROVIS, PR 00687 - Phone
- (787) 654-9100
Quick Facts
- NPI
- 1538124664
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile